Acadia Pharmaceuticals buy Morgan Stanley
Start price
18.03.24
/
50%
€17.30
Target price
18.03.25
€27.59
Performance (%)
-20.58%
Price
20.05.24
€13.74
Summary
This prediction is currently active. The price of Acadia Pharmaceuticals has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.58%. This prediction currently runs until 18.03.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 0.073% | 0.073% |
iShares Core DAX® | -0.268% | 5.471% |
iShares Nasdaq 100 | 1.854% | 7.851% |
iShares Nikkei 225® | 0.284% | 1.729% |
iShares S&P 500 | 1.178% | 5.269% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Morgan Stanley from $40.00 to $30.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
19.12.23
19.12.23
€36.48
19.12.24
19.12.24
-49.85%
20.05.24
20.05.24